PCSK9 in T-cell function and the immune response

Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) was first reported in 2003 and confirmed to be strongly associated with familial hypercholesterolemia. Small-molecule inhibitors targeting PCSK9 provide an effective and safe method for managing hypercholesterolemia and reducing the card...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuying Wang, Xiaosheng Fang, Jiarui Liu, Xiao Lv, Kang Lu, Yingxue Lu, Yujie Jiang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-024-00712-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items